
ATTEROCOR.COM
AtterocorIs a drug development company focused on the accelerated development of a novel treatment for adrenal cancer. A rare endocrine cancer. March 3, 2015. Atterocor Announces Data Presentations at ENDO 2015. December 11, 2014. Atterocor Expands Phase 1 Trial of ATR-101 to Additional Leading Adrenal Cancer Centers Read More.
http://www.atterocor.com/